recurrent herpes labialis. Herpesviral vesicular dermatitis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Inclusion: People 18 to 70 years old with recurrent herpes labialis that Less than 12 hours have passed vesicate. Exclusion criteria: Pregnancy and lactatin; use the antiviral drug in the past two weeks; have a history of immunotherapy in the last year; stimulating the immune system in the last month; Other mucocutaneous disorders; history of RAS ;history of allergy to the plant used in the study of allergic reaction during the study
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical symptoms of blisters. Timepoint: Baseline and End-of-trial. Method of measurement: Observation.;Burning. Timepoint: At days 0, 2, 4, 7. Method of measurement: VAS.;Iitching. Timepoint: At days 0, 2, 4, 7. Method of measurement: VAS.;Soreness. Timepoint: At days 0, 2, 4, 7. Method of measurement: VAS.;Tingling. Timepoint: At days 0,2,4,7. Method of measurement: VAS. | — |
Countries
Iran (Islamic Republic of)
Contacts
Kashan University of Medical Sciences